Vienna’s peptide symposium, retatrutide developments and autumn research dates.
Start hereThe 38th European Peptide Symposium runs September 6–11. Researchers will discuss peptide chemistry, biological applications and therapeutic development.
The Vienna programme brings together synthesis, computational tools and the biology of peptides.
Lilly reports positive data from three further phase 3 obesity trials and plans a US FDA submission in the first quarter of 2027. That is a company-announced target; it is not a confirmed approval date or a Canadian authorisation.
EASD’s 62nd annual meeting runs through October 2. Its programme spans basic and clinical research. For readers following metabolic peptides, the official programme is the place to check scheduled presentations.
The 21st Peptide Therapeutics Symposium returns to the Scripps Seaside Forum on October 20–21. Academic and industry researchers will discuss peptide drug development.
Health Canada’s published guidance on peptide drugs and product claims.
Read the regulator’s advisoryHealth Canada’s advisory warns about unauthorised injectable peptide drugs. It explicitly says that “research use only” labelling does not make these products legal or exempt them from regulatory requirements.
When assessing a claim, check the study evidence and the product’s regulatory authorisation alongside the supplier’s description.
AP’s guide to the two compounds, their research literature and the limits of comparison.
A closer look at how AP presents the evidence, distinctions and open questions around these peptides.
An entry point into AP’s longer comparison, with links to the studies discussed.
Read moreContinue into the existing AP library of research articles, educational resources and studies.
Read moreAbout our coverage. Published by Anglo Peptides, a research-product supplier. We prepared the September 6, 2026 briefings with AI assistance using the linked primary sources. The AP library contains our longer research articles.
Coverage is for research and educational reading. It does not establish a product’s safety, efficacy or regulatory status. For health decisions, consult a qualified healthcare professional. Send a correction
